NEW YORK, Jan. 23, 2023 /PRNewswire/ -- Miles GL Capital today introduces the partnership with 57 Capital Advisors, a biotech venture capital firm in New York. Miles GL will add biotech coverage and become a multi-sector hedge fund focusing on both technology and biotech. Dr. Lei Zhong, from 57 Capital Advisors, will join the company as the Senior Partner and Portfolio Manager to lead biotech investment. A team of medical scientists, in association with 57 Capital, will support Dr. Zhong at Miles GL. "This is a meaningful expansion of Miles GL Capital."